Interview Frédéric Revah – CEO, Genethon; President, YposKesi, France (PHARMA Boardroom)

Genethon, a laboratory created by the patient organization AFM-Telethon, is one of the world’s leaders in the development of biotherapies for rare diseases. In this interview Genethon’s CEO Frédéric Revah explains its role in the discovery of innovative therapies since the 1990s and the recent launch of YposKesi, its innovative (and profitable) manufacturing platform.